-
Scandic Trust Group strengthens sales network with First Idea Consultant
-
Probe into Thales defence group looking at Indonesian contract
-
US to cancel flights as longest govt shutdown drags on
-
Home in Nigeria, ex-refugees find themselves in a war zone
-
Doncic's Lakers hold off Wembanyama's Spurs, Blazers silence Thunder
-
For Turkey's LGBTQ community, draft law sparks existential alarm
-
Musk's $1 trillion pay package to face Tesla shareholder vote
-
Tonga rugby league star out of intensive care after seizure
-
Argentine ex-president Kirchner goes on trial in new corruption case
-
Dams, housing, pensions: Franco disinformation flourishes online
-
Endo returns as Japan look to build on Brazil win
-
Franco captivates young Spaniards 50 years after death
-
German steel industry girds for uncertain future
-
IPL champions Bengaluru could be sold for 'as much as $2 billion'
-
Budget impasse threatens Belgium's ruling coalition
-
New Zealand ex-top cop admits to having material showing child abuse, bestiality
-
BoE set for finely balanced pre-budget rate call
-
Australian kingpin obtains shorter sentence over drug charge
-
Weatherald's unenviable Ashes task: fill giant hole at top left by Warner
-
Ovechkin first to score 900 NHL goals as Capitals beat Blues
-
On Mexico City's streets, vendors fight to make it to World Cup
-
Asian markets bounce from selloff as US jobs beat forecasts
-
Philippine death toll tops 140 as typhoon heads towards Vietnam
-
Kyrgios targets 'miracle' Australian Open return after knee improves
-
'AI president': Trump deepfakes glorify himself, trash rivals
-
Belgium probes drone sightings after flights halted overnight
-
Five things to know about 'forest COP' host city Belem
-
World leaders to rally climate fight ahead of Amazon summit
-
Engine fell off US cargo plane before deadly crash: officials
-
Mexican leader calls for tougher sexual harassment laws after attack
-
Meghan Markle set for big screen return: reports
-
Japan deploys troops after wave of deadly bear attacks
-
FIFA announce new peace prize to be awarded at World Cup draw in Washington
-
Australia's Cummins hints at return for second Ashes Test
-
Boeing settles with one plaintiff in 737 MAX crash trial
-
Man City win as Inter stay perfect, Barca held in Champions League
-
French superstar DJ Snake wants new album to 'build bridges'
-
Barca rescue draw at Club Brugge in six-goal thriller
-
Foden hits top form as Man City thrash Dortmund
-
NBA officials brief Congress committee over gambling probe
-
Inter beat Kairat Almaty to maintain Champions League perfection
-
Newcastle sink Bilbao to extend Champions League winning run
-
Wall Street stocks rebound after positive jobs data
-
LPGA, European tour partner with Saudis for new Vegas event
-
Eyes turn to space to feed power-hungry data centers
-
Jazz lose Kessler for season with shoulder injury
-
League scoring leader Messi among MLS Best XI squad
-
MLS bans Suarez for Miami's winner-take-all playoff match
-
McIlroy appreciates PGA of America apology for Ryder Cup abuse
-
Garnacho equaliser saves Chelsea in Qarabag draw
US expands access to abortion pills through pharmacies
Retail pharmacies in the United States will be permitted to sell abortion pills, health officials said Tuesday, a move that could significantly expand access to the procedure after last year's landmark Supreme Court ruling that overturned federal abortion rights.
Regulatory changes announced by the Food and Drug Administration mean that mifepristone, which is the first of two drugs used to terminate a pregnancy, will be available in local drug stores in states where abortion is permitted.
A doctor's prescription will be needed to obtain the pills, which were previously only available from a few mail-order pharmacies or certified doctors and clinics.
Demand for abortion pills has risen since the conservative-dominated Supreme Court made a landmark ruling last June that overturned Roe v. Wade, a 1973 case that had guaranteed women's right to an abortion for half a century.
Abortion pills are already used in more than half of US procedures to terminate a pregnancy, experts say, and they have increasingly become a focus in the political and legal battle for abortion rights since the Supreme Court's controversial decision.
Pharmacies will need to receive certification to dispense the drug, while patients will need to complete a consent form.
The FDA's decision was welcomed by the American Civil Liberties Union.
"We are happy the FDA has increased pharmacy access to this safe and effective medication, relieving one of the agency's needless burdens on mifepristone patients," said Julia Kaye of the ACLU's Reproductive Freedom Project.
Marjorie Dannenfelser, president of the anti-abortion organization Susan B. Anthony List slammed the decision.
"The Biden administration has once again proved that it values abortion industry profits over women's safety and unborn children's lives," Dannenfelser said in a statement.
D.Qudsi--SF-PST